
Spicy!





The Real Time Reverse Transcription Polymerase Chain Reaction (rRT-PCR) test was adopted by the WHO on January 23, 2020 as a means to detecting the SARS-COV-2 virus, following the recommendations of a Virology research group (based at Charité University Hospital, Berlin), supported by the Bill and Melinda Gates Foundation. (For Further details see the Drosten Study)
Exactly one year later on January 20th, 2021, the WHO retracts. They don’t say “We Made a Mistake”. The retraction is carefully formulated.
While the WHO does not deny the validity of their misleading January 2020 guidelines, they nonetheless recommend “Re-testing” (which everybody knows is an impossibility).
The contentious issue pertains to the number of amplification threshold cycles (Ct). According to Pieter Borger, et al
The number of amplification cycles [should be] less than 35; preferably 25-30 cycles. In case of virus detection, >35 cycles only detects signals which do not correlate with infectious virus as determined by isolation in cell culture…(Critique of Drosten Study)
The World Health Organization (WHO) tacitly admits one year later that ALL PCR tests conducted at a 35 cycle amplification threshold (Ct) or higher are INVALID. But that is what they recommended in January 2020, in consultation with the virology team at Charité Hospital in Berlin.
If the test is conducted at a 35 Ct threshold or above (which was recommended by the WHO), segments of the SARS-CoV-2 virus cannot be detected, which means that ALL the so-called confirmed “positive cases” tabulated in the course of the last 14 months are invalid.
According to Pieter Borger, Bobby Rajesh Malhotra, Michael Yeadon, et al, the Ct > 35 has been the norm “in most laboratories in Europe & the US”.
The WHO’s Mea Culpa
Below is the WHO’s carefully formulated “Retraction”. The full text with link to the original document is in annex:
WHO guidance Diagnostic testing for SARS-CoV-2 states that careful interpretation of weak positive results is needed (1). The cycle threshold (Ct) needed to detect virus is inversely proportional to the patient’s viral load. Where test results do not correspond with the clinical presentation, a new specimen should be taken and retested using the same or different NAT technology. (emphasis added)
WHO reminds IVD users that disease prevalence alters the predictive value of test results; as disease prevalence decreases, the risk of false positive increases (2). This means that the probability that a person who has a positive result (SARS-CoV-2 detected) is truly infected with SARS-CoV-2 decreases as prevalence decreases, irrespective of the claimed specificity.
“Invalid Positives” is the Underlying Concept
This is not an issue of “Weak Positives” and “Risk of False Positive Increases”. What is at stake is a “Flawed Methodology” which leads to invalid estimates.
What this admission of the WHO confirms is that the estimate of covid positive from a PCR test (with an amplification threshold of 35 cycles or higher) is invalid. In which case, the WHO recommends retesting: “a new specimen should be taken and retested…”.
The WHO calls for “Retesting”, which is tantamount to “We Screwed Up”.
That recommendation is pro-forma. It won’t happen. Millions of people Worldwide have already been tested, starting in early February 2020. Nonetheless, we must conclude that unless retested, those estimates (according to the WHO) are invalid.
A student at the University of Florida has provided to The College Fix images from a diversity and inclusion training that students are being told to take.
The materials teach that “equity” is fair while “equality” is not, that “whitesplaining” is a “form of racism,” and many other lessons that suggest white people are the problem.
The program consists of a series of multiple choice questions, infographics and videos.
Each of the questions and videos focuses on specific examples of insensitive language and interactions between white students and minorities and highlights what is considered the appropriate interaction in each case.
One question asks whether it’s “cultural appropriation” for a white man to host a “Salsa and Sombreros” themed birthday party. It is, students are told.


John Kerry, special presidential envoy on climate at the State Department, has disclosed millions of dollars in income from stocks—including of oil companies—that he liquidated after he assumed office in January, according to financial disclosure forms obtained by media outlets.
Under federal ethics laws, most political appointees are required to publicly disclose their current and past financial ties for reasons of transparency and public confidence that their policy decisions are free of conflict of interest.
The State Department told Axios, which first reported on the disclosures, that the department’s Ethics Office reviewed Kerry’s assets and investments to identify ones with a significant conflict-of-interest risk, and that “Special Presidential Envoy Kerry agreed to divest the assets identified by the Ethics Office and has done so.”
Kerry also signed a pledge stating he would not take part in decisions involving his former clients and employers, Axios reported.
According to Kerry’s filings, a periodic transaction report (pdf) and a public financial disclosure report (pdf), his total investments were valued between $4.2 million and $15 million. Kerry divested from the stocks in March, about a month and a half after taking over the position of special climate envoy, the forms show.
His investments included a number of oil companies, including Duke Energy, Cimarex, Dominion Energy, and Exelon Corporation.
During the same time that Kerry held investments in oil companies, he served as advisory board chairman for Climate Finance Partners, whose mission is to create “finance solutions that address climate change,” and collected $125,000 in consulting fees from The Rise Fund, which invests in companies in the renewable energy sector, among others.
Kerry also received millions of dollars in salary, consulting fees, and honoraria, including a $5 million salary from Bank of America, and a $112,500 honorarium from MedStar Washington.
Is there a connection between China, Bill Gates, YouTube, and DNA collection?
Recent reports reveal that a Chinese company with connections to the Gates Foundation is involved in COVID-19 testing and poses a potential threat to American privacy, particularly the medical and health data of those who have been tested for COVID-19.
In late January, CBS’ 60 Minutes reported:
“60 Minutes has learned Chinese company BGI Group, the largest biotech firm in the world, offered to build COVID labs in at least six states, and U.S. intelligence officials issued warnings not to share health data with BGI.
The largest biotech firm in the world wasted no time in offering to build and run COVID testing labs in Washington, contacting its governor right after the first major COVID outbreak in the U.S. occurred there. The Chinese company, the BGI Group, made the same offer to at least five other states, including New York and California, 60 Minutes has learned. This, along with other COVID testing offers by BGI, so worried Bill Evanina, then the country’s top counterintelligence officer, that he authorized a rare public warning.”
“Foreign powers can collect, store and exploit biometric information from COVID tests” declared the notice. Evanina believes the Chinese are trying to collect Americans’ DNA to win a race to control the world’s biodata.”
Evanina said a foreign entity could learn about a person’s current or future medical conditions by studying their DNA and using this information to gain a monopoly over necessary drugs and treatments.
BGI Group declined to be interviewed by 60 Minutes and said the idea that Americans genomic data has been compromised by BGI is “groundless”.
Concerns around BGI also arose in late January when Reuters reported that more than 40 publicly available documents and research papers show BGI’s links to the People’s Liberation Army (PLA). Reuters said the research dealt with topics as varied as mass testing for respiratory pathogens to brain science.
You must be logged in to post a comment.